Literature DB >> 29968556

Plasmodium falciparum Histidine-Rich Protein 2 Gene Variation in a Malaria-Endemic Area of Papua New Guinea.

Nigani Willie1, Peter A Zimmerman1, Rajeev K Mehlotra1.   

Abstract

Histidine-rich protein 2 of Plasmodium falciparum (PfHRP2) forms the basis of many current malaria rapid diagnostic tests (RDTs). It is concerning that there are parasites that lack part or all of the pfhrp2 gene, and thus do not express the PfHRP2 protein; such parasites are not identifiable by PfHRP2-detecting RDTs. Very limited information is available regarding pfhrp2 genetic variation in Papua New Guinea (PNG). In the present study, this gene variation was evaluated using 169 samples previously collected from the Wosera area in East Sepik Province of PNG. Molecular diagnosis of these samples showed that 81% were infected, and P. falciparum was present in 91% of those infected samples. One hundred and twenty samples were amplified for pfhrp2 exon-2, from which 12 randomly selected amplicons were sequenced, yielding 18 sequences, all of which were unique. Baker repeat type 2 × type 7 numbers ranged from 0 to 108. Epitope mapping analysis revealed that three major epitopes, DAHHAHHA, AHHAADAHHA, and AHHAADAHH, were present in high prevalence and frequencies. These major epitopes have been shown to be recognized by the monoclonal antibodies 3A4 and PTL-3 (DAHHAHHA), C1-13 (AHHAADAHHA), and S2-5 and C2-3 (AHHAADAHH). This study provides further information on the high genetic variation of pfhrp2 and its unclear relationship with prediction of RDT detection sensitivity, and identifies major epitopes in this gene from PNG. These results could be relevant and useful to understand the genetic diversity of this gene and the performance of current and future RDTs in this malarious region of the world.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29968556      PMCID: PMC6169185          DOI: 10.4269/ajtmh.18-0137

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  36 in total

1.  Higher Complexity of Infection and Genetic Diversity of Plasmodium vivax Than Plasmodium falciparum Across All Malaria Transmission Zones of Papua New Guinea.

Authors:  Abebe A Fola; G L Abby Harrison; Mita Hapsari Hazairin; Céline Barnadas; Manuel W Hetzel; Jonah Iga; Peter M Siba; Ivo Mueller; Alyssa E Barry
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

2.  Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria.

Authors:  Nelson Lee; Joanne Baker; Kathy T Andrews; Michelle L Gatton; David Bell; Qin Cheng; James McCarthy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes.

Authors:  D J Kemp; J K Thompson; D Walliker; L M Corcoran
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 4.  Rapid diagnostic tests for malaria parasites.

Authors:  Anthony Moody
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.

Authors:  Ivor Harris; Wesley W Sharrock; Lisa M Bain; Karen-Ann Gray; Albino Bobogare; Leonard Boaz; Ken Lilley; Darren Krause; Andrew Vallely; Marie-Louise Johnson; Michelle L Gatton; G Dennis Shanks; Qin Cheng
Journal:  Malar J       Date:  2010-09-07       Impact factor: 2.979

6.  Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay.

Authors:  David T McNamara; Laurin J Kasehagen; Brian T Grimberg; Jennifer Cole-Tobian; William E Collins; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

7.  Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria.

Authors:  Thiranut Ramutton; Ilse C E Hendriksen; Juliet Mwanga-Amumpaire; George Mtove; Rasaq Olaosebikan; Antoinette K Tshefu; Marie A Onyamboko; Corine Karema; Kathryn Maitland; Ermelinda Gomes; Samwel Gesase; Hugh Reyburn; Kamolrat Silamut; Kesinee Chotivanich; Kamoltip Promnares; Caterina I Fanello; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White; Arjen M Dondorp; Mallika Imwong; Charles J Woodrow
Journal:  Malar J       Date:  2012-08-16       Impact factor: 2.979

8.  Rapid antigen detection tests for malaria diagnosis in severely ill Papua New Guinean children: a comparative study using Bayesian latent class models.

Authors:  Laurens Manning; Moses Laman; Anna Rosanas-Urgell; Berwin Turlach; Susan Aipit; Cathy Bona; Jonathan Warrell; Peter Siba; Ivo Mueller; Timothy M E Davis
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

9.  Accuracy of an HRP-2/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria.

Authors:  Alexandra J Umbers; Holger W Unger; Anna Rosanas-Urgell; Regina A Wangnapi; Johanna H Kattenberg; Shadrach Jally; Selina Silim; Elvin Lufele; Stephan Karl; Maria Ome-Kaius; Leanne J Robinson; Stephen J Rogerson; Ivo Mueller
Journal:  Malar J       Date:  2015-10-19       Impact factor: 2.979

10.  Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.

Authors:  Brandt Levitt; Andrew Obala; Scott Langdon; David Corcoran; Wendy Prudhomme O'Meara; Steve M Taylor
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

View more
  6 in total

1.  Nationwide Surveillance of Pfhrp2 Exon 2 Diversity in Plasmodium falciparum Circulating in Symptomatic Malaria Patients Living in Ghana.

Authors:  Dorcas G Bredu; George K Ahadzi; Donu Dickson; Nana Y Peprah; Alexander Asamoah; George A Asumah; Benjamin Abuaku; Kwame K Asare; Dorcas Obiri-Yeboah; Colby T Ford; Eugenia Lo; Keziah L Malm; Linda E Amoah
Journal:  Am J Trop Med Hyg       Date:  2022-05-02       Impact factor: 3.707

2.  Genetic Sequence Variation in the Plasmodium falciparum Histidine-Rich Protein 2 Gene from Field Isolates in Tanzania: Impact on Malaria Rapid Diagnosis.

Authors:  Robert D Kaaya; Caroline Amour; Johnson J Matowo; Franklin W Mosha; Reginald A Kavishe; Khalid B Beshir
Journal:  Genes (Basel)       Date:  2022-09-13       Impact factor: 4.141

3.  Deletion patterns, genetic variability and protein structure of pfhrp2 and pfhrp3: implications for malaria rapid diagnostic test in Amhara region, Ethiopia.

Authors:  Irene Molina-de la Fuente; Mulat Yimar; Luz García; Vicenta González; Arancha Amor; Melaku Anegagrie; Agustín Benito; Javier Martínez; Marta Moreno; Pedro Berzosa
Journal:  Malar J       Date:  2022-10-08       Impact factor: 3.469

4.  Impact of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions on malaria control worldwide: a systematic review and meta-analysis.

Authors:  Irene Molina-de la Fuente; Andrea Pastor; Zaida Herrador; Agustín Benito; Pedro Berzosa
Journal:  Malar J       Date:  2021-06-22       Impact factor: 2.979

5.  Plasmodium falciparum histidine-rich protein 2 diversity in Ghana.

Authors:  Otchere Addai-Mensah; Bismarck Dinko; Mark Noagbe; Selassie Louis Ameke; Max Efui Annani-Akollor; Eddie-Williams Owiredu; Kofi Mensah; Richmond Tackie; Eliezer Togbe; Comfort Agyare-Kwabi; Charles Gyasi; Constance Adu-Gyamfi; Alexander Yaw Debrah
Journal:  Malar J       Date:  2020-07-16       Impact factor: 2.979

6.  Genetic variability of Plasmodium falciparum histidine-rich proteins 2 and 3 in Central America.

Authors:  Gustavo Fontecha; Alejandra Pinto; Denis Escobar; Gabriela Matamoros; Bryan Ortiz
Journal:  Malar J       Date:  2019-01-31       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.